Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus

Nidhi Agarwal, Niall Buckley, Natasha Nakra, Philip Gialanella, Weirong Yuan, Jeny P. Ghartey

Research output: Contribution to journalArticle

Abstract

Problem: Genital tract secretions inhibit Escherichia coli (E. coli) through antimicrobial peptides (AMP) secreted by the host and vaginal microbiota. However, there are limited data against group B Streptococcus (GBS). Method of Study: Group B Streptococcus were incubated with cervico-vaginal lavage (CVL) samples from healthy non-pregnant women (n = 12) or synthetic AMP and monitored for bacterial growth using a turbidimetric approach. E. coli inhibitory activity was determined by a colony-forming unit assay. Results: None of the CVL samples inhibited GBS. The human neutrophil peptide-1 and human defensin 5 inhibited GBS growth by ≥80% at concentrations ≥20 μg/mL and ≥50 μg/mL, respectively, while human beta-defensin 2 and LL-37 did not inhibit at highest concentration tested (100 μg/mL). In contrast, all AMP inhibited E. coli. Conclusions: Antimicrobial peptides may protect against E. coli colonization but have more limited activity against GBS. Future studies will focus on augmenting host defense with specific AMP to prevent genitourinary infection with these pathogenic organisms. Copyright

Original languageEnglish (US)
Pages (from-to)499-507
Number of pages9
JournalAmerican Journal of Reproductive Immunology
Volume74
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Streptococcus agalactiae
Vaginal Douching
Peptides
Escherichia coli
Colony-Forming Units Assay
Defensins
Microbiota
Growth
Infection

Keywords

  • Escherichia coli
  • Antimicrobial peptides
  • Cervico-vaginal lavage samples
  • Defensins
  • Female genital tract secretions
  • Group B streptococcus

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus. / Agarwal, Nidhi; Buckley, Niall; Nakra, Natasha; Gialanella, Philip; Yuan, Weirong; Ghartey, Jeny P.

In: American Journal of Reproductive Immunology, Vol. 74, No. 6, 01.12.2015, p. 499-507.

Research output: Contribution to journalArticle

Agarwal, Nidhi ; Buckley, Niall ; Nakra, Natasha ; Gialanella, Philip ; Yuan, Weirong ; Ghartey, Jeny P. / Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus. In: American Journal of Reproductive Immunology. 2015 ; Vol. 74, No. 6. pp. 499-507.
@article{06dcb62e72f44a22aa9bafa1d07a7052,
title = "Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus",
abstract = "Problem: Genital tract secretions inhibit Escherichia coli (E. coli) through antimicrobial peptides (AMP) secreted by the host and vaginal microbiota. However, there are limited data against group B Streptococcus (GBS). Method of Study: Group B Streptococcus were incubated with cervico-vaginal lavage (CVL) samples from healthy non-pregnant women (n = 12) or synthetic AMP and monitored for bacterial growth using a turbidimetric approach. E. coli inhibitory activity was determined by a colony-forming unit assay. Results: None of the CVL samples inhibited GBS. The human neutrophil peptide-1 and human defensin 5 inhibited GBS growth by ≥80{\%} at concentrations ≥20 μg/mL and ≥50 μg/mL, respectively, while human beta-defensin 2 and LL-37 did not inhibit at highest concentration tested (100 μg/mL). In contrast, all AMP inhibited E. coli. Conclusions: Antimicrobial peptides may protect against E. coli colonization but have more limited activity against GBS. Future studies will focus on augmenting host defense with specific AMP to prevent genitourinary infection with these pathogenic organisms. Copyright",
keywords = "Escherichia coli, Antimicrobial peptides, Cervico-vaginal lavage samples, Defensins, Female genital tract secretions, Group B streptococcus",
author = "Nidhi Agarwal and Niall Buckley and Natasha Nakra and Philip Gialanella and Weirong Yuan and Ghartey, {Jeny P.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1111/aji.12427",
language = "English (US)",
volume = "74",
pages = "499--507",
journal = "American Journal of Reproductive Immunology and Microbiology",
issn = "1046-7408",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus

AU - Agarwal, Nidhi

AU - Buckley, Niall

AU - Nakra, Natasha

AU - Gialanella, Philip

AU - Yuan, Weirong

AU - Ghartey, Jeny P.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Problem: Genital tract secretions inhibit Escherichia coli (E. coli) through antimicrobial peptides (AMP) secreted by the host and vaginal microbiota. However, there are limited data against group B Streptococcus (GBS). Method of Study: Group B Streptococcus were incubated with cervico-vaginal lavage (CVL) samples from healthy non-pregnant women (n = 12) or synthetic AMP and monitored for bacterial growth using a turbidimetric approach. E. coli inhibitory activity was determined by a colony-forming unit assay. Results: None of the CVL samples inhibited GBS. The human neutrophil peptide-1 and human defensin 5 inhibited GBS growth by ≥80% at concentrations ≥20 μg/mL and ≥50 μg/mL, respectively, while human beta-defensin 2 and LL-37 did not inhibit at highest concentration tested (100 μg/mL). In contrast, all AMP inhibited E. coli. Conclusions: Antimicrobial peptides may protect against E. coli colonization but have more limited activity against GBS. Future studies will focus on augmenting host defense with specific AMP to prevent genitourinary infection with these pathogenic organisms. Copyright

AB - Problem: Genital tract secretions inhibit Escherichia coli (E. coli) through antimicrobial peptides (AMP) secreted by the host and vaginal microbiota. However, there are limited data against group B Streptococcus (GBS). Method of Study: Group B Streptococcus were incubated with cervico-vaginal lavage (CVL) samples from healthy non-pregnant women (n = 12) or synthetic AMP and monitored for bacterial growth using a turbidimetric approach. E. coli inhibitory activity was determined by a colony-forming unit assay. Results: None of the CVL samples inhibited GBS. The human neutrophil peptide-1 and human defensin 5 inhibited GBS growth by ≥80% at concentrations ≥20 μg/mL and ≥50 μg/mL, respectively, while human beta-defensin 2 and LL-37 did not inhibit at highest concentration tested (100 μg/mL). In contrast, all AMP inhibited E. coli. Conclusions: Antimicrobial peptides may protect against E. coli colonization but have more limited activity against GBS. Future studies will focus on augmenting host defense with specific AMP to prevent genitourinary infection with these pathogenic organisms. Copyright

KW - Escherichia coli

KW - Antimicrobial peptides

KW - Cervico-vaginal lavage samples

KW - Defensins

KW - Female genital tract secretions

KW - Group B streptococcus

UR - http://www.scopus.com/inward/record.url?scp=84983208775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983208775&partnerID=8YFLogxK

U2 - 10.1111/aji.12427

DO - 10.1111/aji.12427

M3 - Article

C2 - 26395128

AN - SCOPUS:84983208775

VL - 74

SP - 499

EP - 507

JO - American Journal of Reproductive Immunology and Microbiology

JF - American Journal of Reproductive Immunology and Microbiology

SN - 1046-7408

IS - 6

ER -